February 16,2006
Senator Grassley's Statement for the Record regarding FDA's Approval Process
Please see the following two documents attached as related files:
(1) Grassley Statement from the Feb. 16 Congressional Record
(2) Report of the Committee Staff Review of the FDA’s Approval Process for the Vagus Nerve Stimulation Therapy System for Treatment-Resistant Depression
Next Article Previous Article
Recent News
- Crapo Statement on Meeting with IRS Commissioner Nominee
- Crapo Announces Executive Session to Consider Deputy Treasury Secretary Nomination
- Crapo Announces CMS Nomination Hearing
- Crapo: Faulkender Highly Qualified to Serve as Deputy Treasury Secretary
- Crapo Statement at Deputy Treasury Secretary Nomination Hearing